Wilkinson Honored with New Investigator Award from ISCTM
Samuel Wilkinson, MD, Assistant Professor of Psychiatry and Assistant Director of the Yale Depression Research Program, has been awarded a New Investigator Award from the International Society of CNS Clinical Trials and Methodology (ISCTM).
Depression treatments inspired by ketamine move ahead in tests
Antidepressant drugs that work in hours instead of weeks could be on the market within three years, researchers say. "I think it's highly probable that we'll see some version of one of these treatments being approved in the relatively near future," says Dr. Gerard Sanacora, director of the Yale Depression Research Program.
Suicide prevention and ketamine
Suicide, a significant public health problem, is closely linked with mental health conditions, especially depression. At the Yale Depression Research Clinic, a clinical trial is now underway to determine whether esketamine, a form of the drug ketamine, can help prevent suicide in depressed patients.
New drug shows same antidepressant effect as ketamine, study shows
A drug under development seems to have similar antidepressant effects as previously observed with ketamine, but without the same level of dangerous side effects seen when the anesthetic is abused as a party drug, according to a new Yale-led study. Gerard Sanacora, MD, PhD, professor of psychiatry and director of the Yale Depression Research Program, is first author.
Stress and Resilience Town Halls Are Being Offered
The Yale Department of Psychiatry continues to offer virtual “Stress and Resilience Town Halls” over Zoom that are open to all faculty, residents, and staff at Yale School of Medicine and Yale New Haven Health. Virtual meetings will take place twice daily and run for up to an hour. Individuals can attend as frequently as they like.
Stress and Resilience Town Halls
Beginning Friday, March 20, the Department of Psychiatry will offer virtual “Stress and Resilience town halls” over Zoom that are open to all faculty, residents, students, and staff at Yale School of Medicine and Yale New Haven Health. Virtual meetings will take place twice daily and run for up to an hour. Individuals can attend as frequently as they like.
Yale Scientists Awarded $8.4M Grant to Develop Treatments for Women With Problem Drinking
Yale Department of Psychiatry scientists have been awarded a five-year, $8.4 million federal grant to establish a new research center at Yale that will develop treatments to help women with problem drinking.
Moderate-to-High Posttraumatic Stress Common after Exposure to Trauma, Violence, Study Finds
Over 30 percent of injury survivors who are treated in hospital emergency departments will have moderate-to-severe symptoms of posttraumatic stress disorder (PTSD) at some point in the first year following the initial incident, new research led by the Yale School of Public Health finds.
Yale Genomics Study: Helping Researchers Better Understand the Opioid Epidemic
A human genomics study led by two Yale Department of Psychiatry researchers identified specific genetic regions that link opioid exposure and dependence to neuropsychiatric traits like risk-taking behaviors, alcohol abuse, and depression.
Sullivan, Meyer Awarded Grant to Study Intimate Partner Violence Among Women Living with HIV
Tami Sullivan, PhD, Associate Professor of Psychiatry and Director of Family Violence Research and Programs, and Jaimie Meyer, MD, MS, Assistant Professor of Medicine and Assistant Clinical Professor of Nursing, have been awarded a new grant to study intimate partner violence among women living with HIV.
Cook: Dear Donna Rotunno: Sexual Assault Is A Public Health Crisis. Your Reckless Words Hurt All Of Us.
Yale Psychiatry's Joan Cook, PhD, and Anne P. DePrince, PhD, of the University of Denver, respond to an op-ed written by Harvey Weinstein's lawyer, Donna Rotunno, in which Rotunno chastised the public and the media for "pre-determining guilt" against her client. Cook and DePrince write: "As women and trauma psychologists, we had to catch our breath last week when we heard Rotunno say she's never been sexually assaulted because she never put herself in the position to be victimized. We had already been reeling from the rape myths that Rotunno and her colleagues had promoted at the trial ... These are jaw-dropping mischaracterizations of sexual assault and the potential responses to it. These kinds of misperceptions and flat-out untruths not only hurt survivors' psychological health, but also distort public knowledge, attitudes and behaviors."